TransDerm, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for TransDerm, Inc..The latest application filed is for "manufacture of microstructures".

Company Profile

7.11.22

TransDerm, Inc. - Madison NJ US
Transderm, Inc. - Salt Lake City UT US
Transderm, Inc. - Santa Cruz CA US
TRANSDERM INC. - Seoul KR
Transderm, Inc.; - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Manufacture Of Microstructures App 20210162682 - SPEAKER; Tycho J. ; et al.	2021-06-03
Moisture-responsive Films App 20210000455 - Kaspar; Roger L. ; et al.	2021-01-07
GENE SILENCING IN SKIN USING SELF-DELIVERY siRNA DELIVERED BY A MESO DEVICE App 20200330738 - Kaspar; Roger L. ; et al.	2020-10-22
Moisture-responsive films Grant 10,751,032 - Kaspar , et al. A	2020-08-25
Gene silencing in skin using self-delivery siRNA delivered by a meso device Grant 10,695,548 - Kaspar , et al.	2020-06-30
Microneedle Arrays Formed From Polymer Films App 20190337197 - KASPAR; Roger L. ; et al.	2019-11-07
Microneedle arrays formed from polymer films Grant 10,377,062 - Kaspar , et al. A	2019-08-13
Moisture-responsive Films App 20180345627 - Kaspar; Roger L. ; et al.	2018-12-06
Microneedle Arrays For Active Agent Delivery App 20180001070 - Kaspar; Roger L. ; et al.	2018-01-04
Delivery Of Botulinum With Microneedle Arrays App 20170209553 - Kaspar; Roger L. ; et al.	2017-07-27
Microneedle Arrays For Active Agent Delivery App 20160263362 - Kaspar; Roger L. ; et al.	2016-09-15
METHODS OF TREATING KERATIN HYPERPROLIFERATION DISORDERS USING mTOR INHIBITORS App 20160256443 - Kaspar; Roger Louis ; et al.	2016-09-08
METHODS OF TREATING PAIN AND/OR ITCH WITH SMALL MOLECULE INHIBITORS TARGETING AN mTOR PATHWAY App 20160184279 - Kaspar; Roger L. ; et al.	2016-06-30
Methods of treating keratin hyperproliferation disorders using mTOR inhibitors Grant 9,205,080 - Kaspar , et al. December 8, 2	2015-12-08
COMPOSITIONS FOR TRANSDERMAL DELIVERY OF mTOR INHIBITORS App 20140315942 - Kaspar; Roger L. ; et al.	2014-10-23
Percutaneously Absorbable Preparation Containing Fentanyl And Homologue Thereof App 20140243765 - Yu; Hyun-Suk ; et al.	2014-08-28
Microneedle Arrays Formed From Polymer Films App 20140046262 - Kaspar; Roger L. ; et al.	2014-02-13
Methods and Compositions for Treating Keratin Hyperproliferation Disorders App 20140037768 - Kaspar; Roger Louis ; et al.	2014-02-06
Percutaneous Absorption Preparation Containing Rivastigmine App 20130267916 - Yu; Hyun-Suk ; et al.	2013-10-10
Methods and compositions for transdermal delivery of nucleotides Grant 8,530,436 - Kaspar September 10, 2	2013-09-10
Methods and compositions for treating keratin hyperproliferative disorders Grant 8,476,243 - Kaspar , et al. July 2, 2	2013-07-02
Microneedle arrays formed from polymer films Grant 8,366,677 - Kaspar , et al. February 5, 2	2013-02-05
Methods and compositions for treating pachyonychia congenita Grant 7,723,314 - Kaspar , et al. May 25, 2	2010-05-25

Company Registrations

NCAGE Code	47GR9	TRANSDERM, INC
CAGE Code	47GR9	TRANSDERM, INC
DUNS	557564775	TransDerm, Inc

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.